|drug373||Conventional medicines (Oxygen therapy, alfa interferon via aerosol inhalation, and lopinavir/ritonavir) and Traditional Chinese Medicines (TCMs) granules Wiki||1.00|
There is one clinical trial.
The aim of this study is to test whether Traditional Chinese Medicines (TCMs) are effective and safe for treating COVID-19 infection. After the enrolment of approximately 30 subjects, the recruitment will be paused, and planned interim analysis will be performed to preliminarily investigate the efficacy and safety of TCMs in patients infected with COVID-19.
Description: The incidence rate of acute respiratory distress syndrome (ARDS) developmentMeasure: The incidents of acute respiratory distress syndrome (ARDS) development Time: 14 days
Description: Time to complete remission of fever in eligible subjectsMeasure: The time to fever resolution rate Time: 14 days
Description: improvement of chest radiographic evidence indirectly reflects recovery in patients infected with COVID-19.Measure: Time to recovery of lung injury Time: 14 days
Description: The rate of subject who die will be described.Measure: Rate of subjects who die Time: 28 days
Description: The rate of subjects with severe 2019-nCoV infection who receive systematic corticosteroids will be described.Measure: Rate of subjects receiving systematic corticosteroids Time: 28 days
Description: The length of hospital staysMeasure: The length of hospital stays Time: 28 days
Description: The duration of respiratory support including invasive and non-invasive mechanical ventilationMeasure: The duration of respiratory support Time: 28 days